These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5014505)

  • 1. Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives.
    Gray GD; Nichol FR; Mickelson MM; Camiener GW; Gish DT; Kelly RC; Wechter WJ; Moxley TE; Neil GL
    Biochem Pharmacol; 1972 Feb; 21(4):465-75. PubMed ID: 5014505
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity.
    Gish DT; Kelly RC; Camiener GW; Wechter WJ
    J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic nucleotide analogs as carcinostatic agents.
    LePage GA; Hersh EM
    Biochem Biophys Res Commun; 1972 Mar; 46(5):1918-22. PubMed ID: 5015235
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleic acids. l3. 3'-O- and 2'-O-esters of 1- -D-arabinofuranosylcytosine as antileukemic and immunosuppressive agents.
    Warner DT; Neil GL; Taylor AJ; Wechter WJ
    J Med Chem; 1972 Aug; 15(8):790-2. PubMed ID: 5044294
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosine.
    Gish DT; Neil GL; Wechter WJ
    J Med Chem; 1971 Sep; 14(9):882-3. PubMed ID: 5140018
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of phytohemagglutinin on humoral antibody response, delayed hypersensitivity, and homograft rejection.
    Ono K; Blanchard H; Kashiwagi N; MacSween RN; Claman HN; Starzl TE
    Surgery; 1970 Feb; 67(2):322-7. PubMed ID: 4903932
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates.
    Long RA; Szekeres GL; Khwaja TA; Sidwell RW; Simon LN; Robins RK
    J Med Chem; 1972 Dec; 15(12):1215-8. PubMed ID: 4344168
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the immunosuppressive properties of asparaginase.
    Weksler ME; Weksler BB
    Immunology; 1971 Jul; 21(1):137-50. PubMed ID: 4397660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
    Skipper HE; Perry S
    Cancer Res; 1970 Jun; 30(6):1883-97. PubMed ID: 4917694
    [No Abstract]   [Full Text] [Related]  

  • 11. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
    Atassi G; Schaus C; Tagnon HJ
    Eur J Cancer (1965); 1975 Sep; 11(9):609-14. PubMed ID: 1220976
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine.
    Renis HE; Hollowell CA; Underwood GE
    J Med Chem; 1967 Sep; 10(5):777-82. PubMed ID: 4292736
    [No Abstract]   [Full Text] [Related]  

  • 13. ara-Cytidine acylates. Use of drug design predictors in structure-activity relationship correlation.
    Wechter WJ; Johnson MA; Hall CM; Warner DT; Berger AE; Wenzel AH; Gish DT; Neil GL
    J Med Chem; 1975 Apr; 18(4):339-44. PubMed ID: 1120999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biologic examination of some derivatives of 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride (NSC-145668).
    Moffatt JG; Hamamura EK; Russell AF; Prystasz M; Verheyden JP; Yamaguchi K; Uchida N; Sato K; Nishiyama S; Shiratori O; Katagiri K
    Cancer Chemother Rep; 1974; 58(4):451-69. PubMed ID: 4854565
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of DNA in human lymphocytes: possible control mechanism.
    Fridlander BR; Medrano E; Mordoh J
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1128-32. PubMed ID: 4524623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical studies of a new antitumor agent, O2,2'-cyclocytidine.
    Ho DH
    Biochem Pharmacol; 1974 Apr; 23(8):1235-44. PubMed ID: 4824772
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunosuppressive effect of amantadine upon the response of lymphocytes to specific antigens in vitro.
    Mardiney MR; Bredt AB
    Transplantation; 1971 Sep; 12(3):183-8. PubMed ID: 5568073
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
    Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and physicochemical, antimitogenic, and antiviral properties of a novel palladium (II) coordination compound.
    Tayim HA; Malakian AH; Bikhazi AB
    J Pharm Sci; 1974 Sep; 63(9):1469-70. PubMed ID: 4473534
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.